Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th
Go back to Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th| (NASDAQ: ATRA) | Delayed: 8.93 -0.45 (4.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.38 | 52 Week High | $40.80 | |||
| Open | $9.30 | 52 Week Low | $12.45 | |||
| Day High | $9.60 | P/E | N/A | |||
| Day Low | $8.93 | EPS | $0.00 | |||
| Volume | 27,234 | |||||
